"Trump Opioid Commission Looks To Streamline Funding Requests Without Additional Cash" - Steven Ross Johnson
While President Donald Trump’s opioid commission made several recommendations that highlighted the need for greater treatment access, the final report didn't address the insurance and cost issues that affect recovery. The Commission on Combating Drug Addiction and the Opioid Crisis proposed 56 recommendations in its final report, many of which were designed to ease federal regulations that critics say have hindered efforts to expand access to treatment. The report also urged federal agencies to require providers to review their state prescription drug monitoring programs and integrate PDMP data into electronic health records so clinicians can review that information without disrupting workflows. "It is one of the most basic things, and I think many prescribers have not understood the importance of checking the PDMP before even sitting down with the patient," said Michael Fiori, MD, director of addiction services at Mount Sinai Beth Israel and senior faculty of psychiatry at the Icahn School of Medicine at Mount Sinai.
- Michael Fiori, MD, Director, Addiction Services, Mount Sinai Beth Israel, Senior Faculty, Psychiatry, Icahn School of Medicine at Mount Sinai
Mount Sinai Announces Major Step Forward in $1 Billion Downtown Transformation
Jul 22, 2019 View All Press Releases